Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose PK/PD study of E5501 in healthy Japanese male adults
jRCT2080222024Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag in Thrombocytopenia (3 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Pharmacokinetic parameters of E5501 and Pharmacodynamic effects on platelets.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on jRCT2080222024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222024.